Our leadership team is united by a strong set of values and beliefs, and a commitment to help the lives of patients with unmet medical needs around the world.
We joined Idis to become a member of a community whose collective ambition is to find ethical access solutions to medicines outside the clinical trial and commercial settings that meet the unmet medical needs of patients. We are passionate about our responsibility.
Tony has over 20 years senior executive experience in the pharmaceutical industry with a specific focus on global operations and commercial relationships. He joined Idis from Schering Plough in 2006 as Operations Director, becoming Managing Director of the European Operation in 2010.
Prior to joining Idis, Tony held the position of Head of Supply Chain for UK and Ireland at Schering-Plough before which he was with Bio Products Laboratory for 15 years as Head of Operations.
Dr. Gagnon has more than twenty years of leadership experience in the medical, regulatory and safety aspects of pharmaceutical product development, including senior management positions in both academia and in the pharmaceutical and CRO industries.
Formerly she was CMO and Executive Vice President at ICON Clinical Research for nearly ten years, and more recently the CMO at NuPath, Inc.
Dr. Gagnon received her medical degree from Boston University School of Medicine with distinction. She performed postgraduate clinical research at the University of Miami School of Medicine, including studies of the treatment of HIV in one of the first NIAID-sponsored AIDS Clinical Trials Groups.
She is an international editorial advisor to Elsevier Publishing, the author or co-author of numerous publications, abstracts and book chapters and a frequent international speaker.
Charles is a distinguished leader, strategist, and negotiator with a proven track record of leading and closing large scale global transactions. He was previously Senior VP, Corporate Development at Mars Inc., prior to which he spent 11 years with Bristol Myers Squibb, where as VP, Corporate Development, he was integral in the various transactions that transformed BMS from a broad based healthcare and consumer company into a BioPharmaceutical business.
As President of the Established Brands division, Charles is responsible for developing innovative partnerships with pharmaceutical and biotech companies to enable continued patient access to their marketed products throughout the world.
Charles holds a BA from Tufts University and a JD from Pace University. He and his family currently live in McLean, VA.
Following a senior executive sales career in the pharmaceutical industry, latterly at Servier Laboratories, Simon joined Idis as Business Development Director from Quintiles in 2008.
In 2010 he became Senior Vice President, Strategy & Corporate Development, a global role that includes strategy, marketing, public affairs and new service development.
Simon has a deep understanding of the environment and international landscape for managed access. He is a regular spokesperson and author on behalf of Idis and regularly speaks at international conferences on the subject of access to medicines.
Maxine joined Idis in 2005 as UK Customer Services Manager following a career in IT services and the recruitment industry.
Growing with the company, she became Head of Sales and Client Services in 2007 and became Head of Program Management, Managed Access Division in 2009, leading the existing service platform developing a globalizing operation in order to support the increasing needs of our pharmaceutical and biotechnology clients.
An industry expert in developing, managing and implementing global managed access programs and solutions to meet the critical needs of patients around the world, Maxine became Divisional Vice President, Managed Access Programs, in 2011.
Richard joined Idis from the UK retail sector as Financial Controller in 2008. He became European Finance Director in 2011 and was appointed Group Finance Director in 2012.
Richard qualified as a Chartered Accountant with a Top 20 accountancy firm in the City of London and holds a BA (Hons) degree in Geography from Manchester University.